CFA
MDT icon

Compass Financial Advisors’s Medtronic MDT Stock Holding History

Compass Financial Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,405
Closed -$597K – 56
2023
Q1 		$597K Buy
7,405
+480
+7% +$39.1K 0.76% 45
2022
Q4 		$538K Buy
6,925
+2,086
+43% +$169K 0.73% 45
2022
Q3 		$391K Sell
4,839
-78
-2% -$7.01K 0.58% 62
2022
Q2 		$441K Buy
4,917
+3,022
+159% +$306K 0.6% 55
2022
Q1 		$210K Buy
+1,895
New +$200K 0.23% 130

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Compass Financial Advisors's MDT Position: Q2 2023 in Review

Compass Financial Advisors sold out of Medtronic (MDT) in Q2 2023, closing a stake of 7,405 shares — an estimated $597K sold.

Compass Financial Advisors first reported a position in MDT in Q1 2022 and held it in 5 quarters. The position peaked at $597K in Q1 2023. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Compass Financial Advisors reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Compass Financial Advisors sold 7,405 Medtronic shares in Q2 2023, an estimated $597K.
  • Compass Financial Advisors first reported a position in Medtronic in Q1 2022 and held it in 5 quarters.
  • Compass Financial Advisors's Medtronic position peaked at $597K in Q1 2023.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.